Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Harper

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Plos One|February 2, 2013
Common variation neighbouring micro-RNA 22 is associated with increased left ventricular massAndrew R Harper, Bongani M Mayosi, Antony Rodriguez, et al.
The European Respiratory Journal|June 4, 2026
A self-controlled case series to evaluate the effects of clinical trial eligibility criteria on biologic-associated reductions in severe asthma exacerbations: an analysis of the CHRONICLE StudyErnest Boakye-Dankwa, Steven J Kiddle, Hyewon Nina Koo, et al.
Communications Biology|July 11, 2023
Author Correction: DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targetsArwa Raies, Ewa Tulodziecka, James Stainer, et al.
Communications Biology|November 26, 2022
DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targetsArwa Raies, Ewa Tulodziecka, James Stainer, et al.
European Journal of Human Genetics : EJHG|July 21, 2020
Secondary findings in inherited heart conditions: a genotype-first feasibility study to assess phenotype, behavioural and psychosocial outcomesElizabeth Ormondroyd, Andrew R Harper, Kate L Thomson, et al.
Science Advances|August 26, 2022
Cancer-driving mutations are enriched in genic regions intolerant to germline variationDimitrios Vitsios, Ryan S Dhindsa, Dorota Matelska, et al.
Science Advances|May 8, 2024
Phenome-wide identification of therapeutic genetic targets, leveraging knowledge graphs, graph neural networks, and UK Biobank dataLawrence Middleton, Ioannis Melas, Chirag Vasavda, et al.
Circulation. Genomic and Precision Medicine|April 5, 2023
Genetic Determinants of the Interventricular Septum Are Linked to Ventricular Septal Defects and Hypertrophic CardiomyopathyMengyao Yu, Andrew R Harper, Matthew Aguirre, et al.
American Journal of Human Genetics|February 22, 2023
Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK BiobankAbhishek Nag, Ryan S Dhindsa, Lawrence Middleton, et al.
Circulation. Genomic and Precision Medicine|January 4, 2023
Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic CardiomyopathyNay Aung, Luis R Lopes, Stefan van Duijvenboden, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Plos One|February 2, 2013
Common variation neighbouring micro-RNA 22 is associated with increased left ventricular massAndrew R Harper, Bongani M Mayosi, Antony Rodriguez, et al.
The European Respiratory Journal|June 4, 2026
A self-controlled case series to evaluate the effects of clinical trial eligibility criteria on biologic-associated reductions in severe asthma exacerbations: an analysis of the CHRONICLE StudyErnest Boakye-Dankwa, Steven J Kiddle, Hyewon Nina Koo, et al.
Communications Biology|July 11, 2023
Author Correction: DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targetsArwa Raies, Ewa Tulodziecka, James Stainer, et al.
Communications Biology|November 26, 2022
DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targetsArwa Raies, Ewa Tulodziecka, James Stainer, et al.
European Journal of Human Genetics : EJHG|July 21, 2020
Secondary findings in inherited heart conditions: a genotype-first feasibility study to assess phenotype, behavioural and psychosocial outcomesElizabeth Ormondroyd, Andrew R Harper, Kate L Thomson, et al.
Science Advances|August 26, 2022
Cancer-driving mutations are enriched in genic regions intolerant to germline variationDimitrios Vitsios, Ryan S Dhindsa, Dorota Matelska, et al.
Science Advances|May 8, 2024
Phenome-wide identification of therapeutic genetic targets, leveraging knowledge graphs, graph neural networks, and UK Biobank dataLawrence Middleton, Ioannis Melas, Chirag Vasavda, et al.
Circulation. Genomic and Precision Medicine|April 5, 2023
Genetic Determinants of the Interventricular Septum Are Linked to Ventricular Septal Defects and Hypertrophic CardiomyopathyMengyao Yu, Andrew R Harper, Matthew Aguirre, et al.
American Journal of Human Genetics|February 22, 2023
Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK BiobankAbhishek Nag, Ryan S Dhindsa, Lawrence Middleton, et al.
Circulation. Genomic and Precision Medicine|January 4, 2023
Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic CardiomyopathyNay Aung, Luis R Lopes, Stefan van Duijvenboden, et al.
Pageof 5